Cargando…

Pharmacological immunosuppressive agents.

Detalles Bibliográficos
Autor principal:	Salaman, J. R.
Formato:	Texto
Lenguaje:	English
Publicado:	Ulster Medical Society 1981
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2385774/ https://www.ncbi.nlm.nih.gov/pubmed/7015656

Ejemplares similares

Tumour Promotion in Mouse Skin by Sclerosing Agents
por: Salaman, M. H., et al.
Publicado: (1957)

Pharmacologic immunosuppression of mononuclear phagocyte phagocytosis by caffeine
por: Steck, Ryan P., et al.
Publicado: (2015)

Cardiovascular effects of immunosuppression agents
por: Elezaby, Aly, et al.
Publicado: (2022)

Potential of immunosuppressive agents in cerebral ischaemia
por: Gupta, Yogendra Kumar, et al.
Publicado: (2011)

Nonimmunologic targets of immunosuppressive agents in podocytes
por: Yoo, Tae-Hyun, et al.
Publicado: (2015)

Antineoplastic and Immunosuppressive Agents—Part 1
por: Lajtha, L. G.
Publicado: (1975)

New immunosuppressive agents in pediatric transplantation
por: Nguyen, Christina, et al.
Publicado: (2014)

Advances in Immunosuppressive Agents Based on Signal Pathway
por: Xu, Zhiqing, et al.
Publicado: (2022)

Effect of Immunosuppressive Agents on Hepatocyte Apoptosis Post-Liver Transplantation
por: Lim, Eu Jin, et al.
Publicado: (2015)

Immunosuppressant Agents in the Treatment of Glomerulonephritis: Part 1. Corticosteroid Drugs
por: Cameron, J. S.
Publicado: (1971)

Immunosuppressant Agents in the Treatment of Glomerulonephritis: Part 2. Cytotoxic Drugs
por: Cameron, J. S.
Publicado: (1971)

Effects of immunosuppressive agents on the hemostatic system in normal dogs
por: Thomason, John M., et al.
Publicado: (2018)

Simplified immunosuppressive and neuroprotective agents based on gracilin A
por: Abbasov, Mikail E., et al.
Publicado: (2019)

COVID-19 in rheumatic disease patients on immunosuppressive agents
por: Sharmeen, Saika, et al.
Publicado: (2020)

The Immunosuppressive Agent Mizoribine Monophosphate Is an Inhibitor of the Human RNA Capping Enzyme
por: Picard-Jean, Frédéric, et al.
Publicado: (2013)

Prospective study of live attenuated vaccines for patients receiving immunosuppressive agents
por: Kamei, Koichi, et al.
Publicado: (2020)

Onychomycosis in Psoriatic Patients with Nail Disorders: Aetiological Agents and Immunosuppressive Therapy
por: Alves, Núbia Carvalho Pena de Oliveira Praeiro, et al.
Publicado: (2020)

Emphysematous cystitis in a patient using immunosuppressant agents
por: Yokokawa, Daiki, et al.
Publicado: (2020)

Live attenuated vaccines in patients receiving immunosuppressive agents
por: Kamei, Koichi
Publicado: (2023)

Viewpoint about biologic agents for psoriasis: are they immunosuppressants or immunomodulators?
por: Metko, Dea, et al.
Publicado: (2023)

The Sensitivity to Chemotherapeutic Agents of a Rat Tumour Grown in Immunosuppressed Mice
por: Sheard, Christine E., et al.
Publicado: (1971)

Novel amides of mycophenolic acid and some heterocyclic derivatives as immunosuppressive agents
por: Walczak, Juliusz Maksymilian, et al.
Publicado: (2022)

Conventional immunosuppressive therapy in severe Behcet’s Uveitis: the switch rate to the biological agents
por: Celiker, Hande, et al.
Publicado: (2018)

Pharmacologic Agents for Chronic Diarrhea
por: Lee, Kwang Jae
Publicado: (2015)

Agent‐Based Modeling in Systems Pharmacology
por: Cosgrove, J, et al.
Publicado: (2015)

Inhibition of HIV replication in vitro by clinical immunosuppressants and chemotherapeutic agents
por: Hawley, Todd, et al.
Publicado: (2013)

Enterocolic Lymphocytic Phlebitis Treated Preoperatively with Biologics and Immunosuppressive Agents
por: Okano, Soh, et al.
Publicado: (2022)

Pharmacokinetics of immunosuppressive agents during hemoperfusion in a sheep model
por: Leber, Bettina, et al.
Publicado: (2023)

Human Monocyte-Derived Dendritic Cells Are the Pharmacological Target of the Immunosuppressant Flavonoid Silibinin
por: Pagano, Maria Teresa, et al.
Publicado: (2022)

Safety and efficacy of the immunosuppressive agent 6-tioguanine in murine model of acute and chronic colitis
por: Kverka, Miloslav, et al.
Publicado: (2011)

Regulatory effect of immunosuppressive agents in mice with renal ischemia reperfusion injury
por: Zhang, Wei, et al.
Publicado: (2018)

Patients with MS treated with immunosuppressive agents: Across the COVID-19 spectrum
por: Louapre, C., et al.
Publicado: (2020)

Methotrexate as a safe immunosuppressive agent during the COVID-19 pandemic
por: Ganjei, Zakiye, et al.
Publicado: (2021)

Pharmacological agents for the prevention of colistin-induced nephrotoxicity
por: Mirjalili, Mahtabalsadat, et al.
Publicado: (2022)

Salivating for Knowledge: Potential Pharmacological Agents in Tick Saliva
por: Hovius, Joppe W. R, et al.
Publicado: (2008)

Toxoplasmosis in patients with an autoimmune disease and immunosuppressive agents: A multicenter study and literature review
por: Durieux, Marie-Fleur, et al.
Publicado: (2022)

Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder
por: Burnette, Elizabeth M., et al.
Publicado: (2022)

Recapturing adequate control of psoriasis by additional immunosuppressive agents alongside ustekinumab
por: Jayasekera, Prativa S., et al.
Publicado: (2016)

Development of Non-Immunosuppressive FK506 Derivatives as Antifungal and Neurotrophic Agents
por: Jung, Jin A, et al.
Publicado: (2020)

MRI Contrast Agents for Pharmacological Research
por: Terreno, Enzo, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_d1hvj742sf13gd4234f9447onk